Notice to stakeholders: Harmonizing fludeoxyglucose (F-18 FDG) product monographs

Notice to stakeholders: Harmonizing fludeoxyglucose (F-18 FDG) product monographs Health Canada recommends modified wording for the indications and clinical uses of fludeoxyglucose (F-18 FDG) products in their product monographs. The modified wording aims to bring the indications and clinical uses for F-18 FDG up-to-date and harmonize the product monographs in this regard. 2021-12-29 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetyharmonizing product monographsfludeoxyglucoseF-18 FDGindications-and-clinical-usesindications-and-clinical-uses for F-18 FDG Notice to stakeholders: Harmonizing fludeoxyglucose (F-18 FDG) product monographsHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/harmonizing-fludeoxyglucose-product-monographs.html Notice to stakeholders: Harmonizing fludeoxyglucose (F-18 FDG) product monographsHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/harmonisation-monographies-produits-fluorodesoxyglucose.html

Health Canada recommends modified wording for the indications and clinical uses of fludeoxyglucose (F-18 FDG) products in their product monographs. The modified wording aims to bring the indications and clinical uses for F-18 FDG up-to-date and harmonize the product monographs in this regard.

Data and Resources

Similar records